At the Cleveland Clinic, doctors are using a one-time gene-editing therapy that alters a patient’s own blood-forming stem cells to correct the genetic mutation responsible for the disease. Physicians ...
SAN DIEGO — A newly approved gene therapy product for sickle cell disease, lovotibeglogene autotemcel (lovo-cel, marketed as Lyfgenia), led to durable disease remissions for up to 5 years and almost ...
LINCOLN, Neb. (KOLN) - Groundbreaking advancements in Sickle Cell treatment are changing and saving lives nationwide. For decades, patients with Sickle Cell Disease have lived with pain, complications ...
This story is the first in an occasional series following Louisiana’s first patients to receive gene therapy for sickle cell disease. On the third floor of Manning Family Children’s Hospital in New ...
21 year old Sebastien Beauzile celebrates his Lyfgenia infusion with his medical team. Four months later, his doctors consider him cured from sickle cell anemia. A 21 year old man in New York has been ...
Scientists at St. Jude Children's Research Hospital and Northwestern University identified a previously unknown treatment opportunity for sickle cell disease and β-thalassemia. The discovery, ...
COLUMBUS, Ga. (WRBL) — September is Sickle Cell Awareness Month, and millions of people worldwide are living with the disease. But advances in treatment are being made. WRBL News 3 anchor Cameron ...
A Fayetteville teen is making history in North Carolina after undergoing a new gene therapy for sickle cell disease. Aaron Scott was diagnosed with sickle cell at birth. Other WRAL Top Stories Sickle ...
Major is one of the first pediatric patients in Florida to receive gene therapy for sickle cell disease since the FDA ...
But new gene therapies — two of which will submit for FDA approval by the end of March — offer what could be a life-changing alternative for sickle cell patients in Louisiana, which has the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results